Ting Chang, Md

This early-stage trial is testing a new type of immune cell therapy called CD19-BCMA CAR-T in 9 adults with severe myasthenia gravis that hasn't improved with standard treatments. The therapy uses a patient's own modified immune cells to target and attack the faulty cells causing…